Provided by Tiger Fintech (Singapore) Pte. Ltd.

Globus Medical

72.76
-0.3100-0.42%
Volume:134.99K
Turnover:9.80M
Market Cap:10.01B
PE:97.01
High:72.90
Open:72.90
Low:72.21
Close:73.07
Loading ...

GMED Stock Jumps 41.8% in a Year: What's Behind the Rally?

Zacks
·
21 Mar

Should You Hold Globus Medical Stock in Your Portfolio Now?

Zacks
·
19 Mar

Globus Medical Expands Anterior Spine Portfolio With Two New Offerings

Zacks
·
14 Mar

Globus Medical extends versatility of Advanced Materials Science™ anterior interbody portfolio with launch of COHERE™ ALIF Spacer and Modulus™ ALIF Blades

GlobeNewswire
·
12 Mar

Globus Medical to feature ExcelsiusFlex™ for Total Knee Arthroplasty at the American Academy of Orthopedic Surgeons Annual Meeting

GlobeNewswire
·
07 Mar

Globus Medical to participate in the Canaccord Genuity 2025 Musculoskeletal Conference

GlobeNewswire
·
06 Mar

Is the Options Market Predicting a Spike in Globus Medical (GMED) Stock?

Zacks
·
05 Mar

There May Be Reason For Hope In Globus Medical's (NYSE:GMED) Disappointing Earnings

Simply Wall St.
·
05 Mar

Globus Medical's (NYSE:GMED) Soft Earnings Don't Show The Whole Picture

Simply Wall St.
·
05 Mar

Is Globus Medical, Inc. (GMED) the Best Medical Technology Stock to Buy According to Analysts?

Insider Monkey
·
05 Mar

Nevro Corp Q4 Shr View $-0.77 -- Lseg Ibes Data

THOMSON REUTERS
·
05 Mar

Nevro Corp Qtrly Loss per Share $1.41

THOMSON REUTERS
·
05 Mar

Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results

PR Newswire
·
05 Mar

Globus Medical (GMED) Gets a Buy from Morgan Stanley

TIPRANKS
·
25 Feb

Globus Medical Is Maintained at Overweight by Barclays

Dow Jones
·
24 Feb

Globus Medical price target raised to $103 from $100 at Barclays

TIPRANKS
·
24 Feb

Is Globus Medical, Inc. (NYSE:GMED) Trading At A 32% Discount?

Simply Wall St.
·
22 Feb

Globus Medical’s Earnings Call: Record Revenue and Growth

TIPRANKS
·
22 Feb

JMP Securities Remains a Hold on Globus Medical (GMED)

TIPRANKS
·
22 Feb

Stock Track | Globus Medical Plummets 5.37% Despite Q4 Earnings Beat as Analyst Cuts Price Target

Stock Track
·
22 Feb